SAI Updates Regarding COVID-19

SAI is monitoring the COVID-19 pandemic and reviewing our business continuity plans daily. 

At this time, our production is fully operational and we have not identified any issues related to logistics, supplies, or other resources, that will affect our ability to continue supporting our clients. 

We know that the work our customers do to support pharmaceutical development is essential. We will do all we can to be here for you throughout this time, and will let you know as soon as possible if things change by updating this page and our LinkedIn page.